11:11 AM EDT, 04/11/2024 (MT Newswires) -- European equities traded in the US as American depositary receipts were weaker Thursday morning, falling 0.91% to 1,353.49 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by semiconductor company Sequans Communications ( SQNS ) and internet browser company Opera (OPRA), which rose 5.6% and 4.9% respectively. They were followed by biopharmaceutical companies DBV Technologies ( DBVT ) and Cellectis ( CLLS ) , which increased 1.9% and 0.4% respectively.

The decliners from continental Europe were led by biopharmaceutical companies Calliditas Therapeutics ( CALT ) and Grifols ( GRFS ) , which fell 6% and 5.2% respectively. They were followed by biotech firms Evaxion Biotech ( EVAX ) and Biophytis ( BPTS ) , which dropped 4.5% and 3.7% respectively.

From the UK and Ireland, the gainers were led by biotech firm Autolus Therapeutics ( AUTL ) and biopharmaceutical company Akari Therapeutics ( AKTX ) , which were up 3.1% and 1.5% respectively. They were followed by biopharmaceutical company TC Biopharm ( TCBP ) and pharmaceutical company AstraZeneca ( AZN ) , which rose 1.4% each.

The decliners from the UK and Ireland were led by pharmaceutical company Avadel Pharmaceuticals ( AVDL ) and biotech firm Trinity Biotech ( TRIB ) , which lost 4% and 3.1% respectively. They were followed by financial services companies Barclays ( JJCTF ) and HSBC ( HSBC ) , which were off 2.8% and 2.7% respectively.